The research advance represents a 1,000-fold improvement in speed and throughput in Brillouin microscopy, according to the ...

MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.

Funding from Cancer Prevention and Research Institute of Texas has brought more than 324 distinguished cancer researchers to Texas.

Incyte and Genesis Therapeutics have agreed to discover and optimize at least two initial small molecule compounds through Genesis’s AI platform, Genesis Exploration of Molecular Space (GEMS).

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat chronic infections for the first time.

Some of the funds will be used to develop multiomics solutions based on Atrandi's proprietary technology for single-cell ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

Running a multi-product facility requires expertise. And, while technology is important, human expertise remains the most ...

The Mt. Sinai study could open the door to future therapies for Alzheimer’s, amyotrophic lateral sclerosis, brain cancer, and ...

Evo 2 now includes information from humans, plants, and other eukaryotic species to expand its capabilities in generative functional genomics.

Researchers say study provides sufficient rationale to further explore the therapeutic uses of SSRIs during infection.

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.